Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of an anti-retroviral combination regimen including either efavirenz or lopinavir-ritonavir with a backbone of two nucleoside reverse transcriptase inhibitors.
Panagopoulos P, Tsiodras S, Antoniadou A, Katsarolis I, Papadopoulos A, Poulakou G, Giamarellou H. Panagopoulos P, et al. Among authors: poulakou g. Clin Microbiol Infect. 2006 May;12(5):486-9. doi: 10.1111/j.1469-0691.2006.01372.x. Clin Microbiol Infect. 2006. PMID: 16643529 Free article.
Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology.
Poulakou G, Katsarolis I, Matthaiopoulou I, Tsiodras S, Kanavaki S, Hatzaki D, Roilides E, Sofianou D, Kavaliotis I, Kansouzidou A, Kafetzis DA, Paraskakis I, Foustoukou M, Daikos GL, Syriopoulou V, Pangalis A, Leveidiotou S, Giamarellou H; Hellenic Study Group for the Susceptibility of Streptococcus pneumoniae. Poulakou G, et al. Int J Antimicrob Agents. 2007 Jul;30(1):87-92. doi: 10.1016/j.ijantimicag.2007.03.011. Epub 2007 May 30. Int J Antimicrob Agents. 2007. PMID: 17540542
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.
Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, Karaiskos I, Poulakou G, Kontopidou F, Armaganidis A, Cars O, Giamarellou H. Plachouras D, et al. Among authors: poulakou g. Antimicrob Agents Chemother. 2009 Aug;53(8):3430-6. doi: 10.1128/AAC.01361-08. Epub 2009 May 11. Antimicrob Agents Chemother. 2009. PMID: 19433570 Free PMC article. Clinical Trial.
215 results